Boosting collaboration
March 9, 2012
THE collaboration between the
TGA, EMA, EU member states, and
the FDA, on good manufacturing
practice (GMP) inspections of
active substance manufacturers is
set to be expanded to include a
new partner, the World Health
Organisation (WHO).
The collaboration allows
participants to share information
on inspections, including planning,
policy and reports, for makers of
active pharmaceutical ingredients
that are located outside the
participating countries, and also
allows for joint inspections by
participants of facilities.
WHO will participate in the group
through its Prequalification of
Medicines Programme.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Mar 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Mar 12